Testing NMDA Receptor Block as a Therapeutic Strategy for Reducing Ischaemic Damage to CNS White Matter

GLIA - United States
doi 10.1002/glia.20608
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

34. Augmenting CNS Glucocerebrosidase Activity as a Therapeutic Strategy for Parkinsonism and Other Gaucher-Related Synucleinopathies

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Left Anterior Fascicular Block: An Ischaemic Response During Treadmill Testing.

Heart
Cardiovascular MedicineCardiology
1991English

Protease-Activated Receptor 1-Dependent Neuronal Damage Involves NMDA Receptor Function

Experimental Neurology
Developmental NeuroscienceNeurology
2009English

Uncoupling NMDA Receptor Mechanism of Ketamine Block and Proton Inhibition

Biophysical Journal
Biophysics
2019English

How Methotrexate Is Involved in the Therapeutic Strategy of CNS Sarcoidosis ?

The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders
2014English

White Matter Plasticity and Enhanced Remyelination in the Maternal CNS

Journal of Neuroscience
Neuroscience
2007English

Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies

OncoImmunology
OncologyAllergyImmunology
2013English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

NMDA Receptor-Dependent Synaptic Reinforcement as a Crucial Process for Memory Consolidation

Science
MultidisciplinaryPhilosophy of ScienceHistory
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy